IL1B and cardiovascular disorder: Moreover, both conditions share key aspects of immune regulation, notably elevated T-cell-mediated responses and inflammatory cytokines like TNFα, IL-6, and IL-1β, reflecting an increased cardiovascular disease risk in ankylosing spondylitis patients (4, 18, 32).